Women with mutations in certain genes are predisposed to a high risk of breast cancer (about 50%) up to an age of 70 years.
A study published by Dr Benjamin Nisman and colleagues have found that DiviTumTM, Biovicas high-precision test to measure cell growth rate, is important when identifying women with high risk to develop breast cancer. Women with increased DiviTumTM values showed a significantly higher risk than others to develop breast cancer (P = 0.04).
The study was published in the scientific journal Cancer Epidemiology, Biomarkers & Prevention. The results can be fundamental and of great value for women when risk- reduction interventions are discussed.
For more information see: